Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 2, 2015, Pages 271-282

  Negrotto, S ^a   Jaquenod De Giusti, C ^b   Rivadeneyra, L ^a   Ure, A E ^b   Mena, H A ^a   Schattner, M ^a   Gomez, R M ^b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Inst de Biotecnología Y Biología Molecular IBBM   (Argentina)

Author keywords

Human enterovirus B; P selectin; Pathogenesis; Platelets; Thrombocytopenia

Indexed keywords

ACTIN; ALPHA INTERFERON; BETA INTERFERON; CAPSID PROTEIN; IMMUNOGLOBULIN G; MESSENGER RNA; PADGEM PROTEIN; PHOSPHATIDYLSERINE; VIRUS RNA; VON WILLEBRAND FACTOR; SELP PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; UPREGULATION; VERO CELL LINE; VIRAL CLEARANCE; VIREMIA; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS MYOCARDITIS; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS VIRULENCE; ANIMAL; BLOOD; C57BL MOUSE; CHLOROCEBUS AETHIOPS; COXSACKIE VIRUS INFECTION; DISEASE MODEL; ENTEROVIRUS B; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MYOCARDITIS; PATHOGENICITY; THROMBOCYTE; TIME; VIROLOGY;

ANIMALS; BLOOD PLATELETS; CAPSID PROTEINS; CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; MALE; MICE, INBRED C57BL; MYOCARDITIS; P-SELECTIN; PHOSPHATIDYLSERINES; RNA, VIRAL; THROMBOCYTOPENIA; TIME FACTORS; VERO CELLS; VIRUS REPLICATION;

EID: 84922768348     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12782     Document Type: Article

References (44)

1. Danon D, Jerushalmy Z, De Vries A. Incorporation of influenza virus in human blood platelets in vitro. Electron microscopical observation. Virology 1959; 9: 719-22.
2. Jerushalmy Z, Kohn A, De Vries A. Interaction of myxoviruses with human blood platelets in vitro. Proc Soc Exp Biol Med 1961; 106: 462-6.
3. Zucker-Franklin D, Seremetis S, Zheng ZY. Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. Blood 1990; 75: 1920-3.
4. Onlamoon N, Noisakran S, Hsiao HM, Duncan A, Villinger F, Ansari AA, Perng GC. Dengue virus-induced hemorrhage in a nonhuman primate model. Blood 2010; 115: 1823-34.
5. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002; 99: 4021-9.
6. Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol 2006; 87: 2243-51.
7. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, Akeda Y, Matias RR, Kuter DJ, Nagata S, Natividad FF, Oishi K. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis 2012; 205: 1321-9.
8. Othman M, Labelle A, Mazzetti I, Elbatarny HS, Lillicrap D. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 2007; 109: 2832-9.
9. Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, Chisari FV, Ruggeri ZM, Guidotti LG. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A. 2008; 105: 629-34.
10. Racaniello VR. Picornaviridae: The Viruses and Their Replication. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM, eds. Virology. Philadelphia: Lippincott Williams & Wilkins, 2001: 559-88.
11. Stanway G, Brown F, Christian P, Hovi T, Hyypiä T, King AMQ, Knowles NJ, Lemon SM, Minor PD, Pallansch MA, Palmenberg AC, Skern T. Picornaviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. Virus taxonomy, VIIIth Report of the ICTV. London, United Kingdom: Elsevier, 2004: 757-78.
12. Pallansch MA, Roos RP. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM, eds. Virology. Philadelphia: Lippincott Williams & Wilkins, 2001: 589-630.
13. Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001; 11: 355-68.
14. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-98.
15. Gupalo E, Buriachkovskaia L, Othman M. Human platelets express CAR with localization at the sites of intercellular interaction. Virol J 2011; 8: 456.
16. Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med 2004; 102: 175-93.
17. Whitton JL. Immunopathology during coxsackievirus infection. Springer Semin Immunopathol 2002; 24: 201-13.
18. Liu Z, Yuan J, Yanagawa B, Qiu D, McManus BM, Yang D. Coxsackievirus-induced myocarditis: new trends in treatment. Expert Rev Anti Infect Ther 2005; 3: 641-50.
19. Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol 2012; 24: 401-7.
20. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 1996; 70: 7811-8.
21. Rinehart JE, Gomez RM, Roos RP. Molecular determinants for virulence in coxsackievirus B1 infection. J Virol 1997; 71: 3986-91.
22. Cifuente JO, Ferrer MF, Jaquenod De Giusti C, Song WC, Romanowski V, Hafenstein SL, Gomez RM. Molecular determinants of disease in coxsackievirus B1 murine infection. J Med Virol 2011; 83: 1571-81.
23. Romorini L, Scassa ME, Richardson GV, Bluguermann C, de Giusti CJ, Questa M, Fernandez Espinosa DD, Gomez RM, Sevlever GE, Miriuka SG. Activation of apoptotic signalling events in human embryonic stem cells upon Coxsackievirus B3 infection. Apoptosis 2012; 17: 132-42.
24. Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 2000; 96: 2834-40.
25. Etulain J, Negrotto S, Carestia A, Pozner RG, Romaniuk MA, D'Atri LP, Klement GL, Schattner M. Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets. Thromb Haemost 2012; 107: 99-110.
26. Negrotto S, De Giusti CJ, Lapponi MJ, Etulain J, Rivadeneyra L, Pozner RG, Gomez RM, Schattner M. Expression and functionality of type I interferon receptor in the megakaryocytic lineage. J Thromb Haemost 2011; 9: 2477-85.
27. Etulain J, Lapponi MJ, Patrucchi SJ, Romaniuk MA, Benzadon R, Klement GL, Negrotto S, Schattner M. Hyperthermia inhibits platelet hemostatic functions and selectively regulates the release of alpha-granule proteins. J Thromb Haemost 2011; 9: 1562-71.
28. Solana ME, Ferrer MF, Novoa MM, Song WC, Gomez RM. Decay-accelerating factor 1 deficiency exacerbates Trypanosoma cruzi-induced murine chronic myositis. Muscle Nerve 2012; 46: 582-7.
29. Rowley JW, Schwertz H, Weyrich AS. Platelet mRNA: the meaning behind the message. Curr Opin Hematol 2012; 19: 385-91.
30. Gupalo E, Kuk C, Qadura M, Buriachkovskaia L, Othman M. Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors. Platelets 2013; 24: 383-91.
31. Ghosh K, Gangodkar S, Jain P, Shetty S, Ramjee S, Poddar P, Basu A. Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy. J Electron Microsc (Tokyo) 2008; 57: 113-8.
32. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11: 264-74.
33. Shimony N, Elkin G, Kolodkin-Gal D, Krasny L, Urieli-Shoval S, Haviv YS. Analysis of adenoviral attachment to human platelets. Virol J 2009; 6: 25.
34. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995; 69: 1903-36.
35. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995; 69: 3873-7.
36. Nicholson-Weller A, March JP, Rosen CE, Spicer DB, Austen KF. Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood 1985; 65: 1237-44.
37. Chung SK, Kim JY, Kim IB, Park SI, Paek KH, Nam JH. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 2005; 333: 31-40.
38. Forghani B, Schmidt NJ. Association of herpes simplex virus with platelets of experimentally infected mice. Arch Virol 1983; 76: 269-74.
39. Bik T, Sarov I, Livne A. Interaction between vaccinia virus and human blood platelets. Blood 1982; 59: 482-7.
40. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A. 1998; 95: 7074-9.
41. Xing L, Huhtala M, Pietiainen V, Kapyla J, Vuorinen K, Marjomaki V, Heino J, Johnson MS, Hyypia T, Cheng RH. Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1. J Biol Chem 2004; 279: 11632-8.
42. Koupenova M, Vitseva O, Mackay CR, Beaulieu LM, Benjamin EJ, Mick E, Kurt-Jones EA, Ravid K, Freedman JE. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood 2014; 124: 791-802.
43. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza PT, Bozza FA. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost 2013; 11: 951-62.
44. Loria GD, Romagnoli PA, Moseley NB, Rucavado A, Altman JD. Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood 2013; 121: 940-50.